Author
Anne-Marie Côté
Other affiliations: Centre Hospitalier Universitaire de Sherbrooke, University of British Columbia
Bio: Anne-Marie Côté is an academic researcher from Université de Sherbrooke. The author has contributed to research in topics: Pregnancy & Medicine. The author has an hindex of 18, co-authored 46 publications receiving 2478 citations. Previous affiliations of Anne-Marie Côté include Centre Hospitalier Universitaire de Sherbrooke & University of British Columbia.
Topics: Pregnancy, Medicine, Proteinuria, Preeclampsia, Blood pressure
Papers
More filters
••
University of Calgary1, McGill University Health Centre2, Cardiovascular Institute of the South3, University of British Columbia4, Université du Québec à Trois-Rivières5, Université de Montréal6, Laval University7, McMaster University8, Alberta Health Services9, University of Alberta10, McGill University11, University of Toronto12, Heart and Stroke Foundation of Canada13, Population Health Research Institute14, Montreal General Hospital15, University of Western Ontario16, Montreal Heart Institute17, Winnipeg Regional Health Authority18, Université du Québec à Montréal19, Northern Ontario School of Medicine20, St. Michael's Hospital21, University of Manitoba22, Centre for Addiction and Mental Health23, University of Ottawa24, University Health Network25, Concordia University Wisconsin26, Ottawa Hospital Research Institute27, University of Ontario Institute of Technology28, Hôpital Maisonneuve-Rosemont29, University of Saskatchewan30, Centre Hospitalier Universitaire Sainte-Justine31, Children's Hospital of Eastern Ontario32, St Thomas' Hospital33, Mount Sinai Hospital, Toronto34, Université de Sherbrooke35, Brown University36, Concordia Hospital37, University of Pennsylvania38
TL;DR: All individuals with hypertension should have an assessment of global cardiovascular risk to promote health behaviours that lower blood pressure, and an angiotensin receptor-neprilysin inhibitor combination should be used in place of either an ang Elliotensin-converting enzyme inhibitor or angiotENSin receptor blocker in individuals with heart failure.
465 citations
••
TL;DR: The current evidence assessed in the clinical practice guideline prepared by the Canadian Hypertensive Disorders of Pregnancy Working Group and published by Pregnancy Hypertension to provide a reasonable approach to the diagnosis, evaluation, and treatment of the hypertensive disorders of pregnancy is presented.
Abstract: Objective: This executive summary presents in brief the current evidence assessed in the clinical practice guideline prepared by the Canadian Hypertensive Disorders of Pregnancy Working Group and published by Pregnancy Hypertension (http://www.pregnancyhypertension.org/article/S22107789(14)00004-X/fulltext) to provide a reasonable approach to the diagnosis, evaluation, and treatment of the hypertensive disorders of pregnancy.
367 citations
••
University of Calgary1, McGill University Health Centre2, Libin Cardiovascular Institute of Alberta3, Cardiovascular Institute of the South4, University of British Columbia5, Université du Québec à Trois-Rivières6, University of Ottawa7, Ottawa Hospital Research Institute8, Winnipeg Regional Health Authority9, Northern Ontario School of Medicine10, Concordia University Wisconsin11, University of Western Ontario12, Centre Hospitalier Universitaire Sainte-Justine13, Heart and Stroke Foundation of Canada14, McMaster University15, McGill University16, Université de Montréal17, University of Ontario Institute of Technology18, Université de Sherbrooke19, Brown University20, St. Michael's Hospital21, Montreal Heart Institute22, National Institutes of Health23, Université du Québec à Montréal24, University of Toronto25, University of Alberta26, University Health Network27, St Thomas' Hospital28, Alberta Health Services29, Laval University30, University of Manitoba31, Centre for Addiction and Mental Health32, Population Health Research Institute33, University of Saskatchewan34, University of Pennsylvania35, Hôpital Maisonneuve-Rosemont36
TL;DR: The 2020 guidelines include new guidance on themanagement of resistant hypertension and the management of hypertension in women planning pregnancy.
275 citations
••
University of Calgary1, McGill University Health Centre2, Libin Cardiovascular Institute of Alberta3, University of British Columbia4, Montreal Children's Hospital5, Université du Québec à Trois-Rivières6, Université de Montréal7, Laval University8, McMaster University9, University of Alberta10, University of Toronto11, Ottawa Hospital Research Institute12, Hôpital Maisonneuve-Rosemont13, University of Western Ontario14, Memorial University of Newfoundland15, Centre for Addiction and Mental Health16, University of Ottawa17, McGill University18, University Health Network19, University of Saskatchewan20, University of Manitoba21, Concordia University Wisconsin22, St. Michael's Hospital23, Montreal General Hospital24, Heart and Stroke Foundation of Canada25, Dalhousie University26, Université de Sherbrooke27, Université du Québec à Montréal28, Montreal Heart Institute29, Population Health Research Institute30, Simon Fraser University31, St George's, University of London32, Centre Hospitalier Universitaire Sainte-Justine33, Children's Hospital of Eastern Ontario34
TL;DR: Hypertension Canada provides annually updated, evidence-based guidelines for the diagnosis, assessment, prevention, and treatment of hypertension, including 10 new guidelines for individuals with non-AOBP readings ≥ 140 mm Hg.
256 citations
••
TL;DR: The spot protein:creatinine ratio is a reasonable “rule-out” test for detecting proteinuria of 0.3 g/day or more in hypertensive pregnancy.
Abstract: Objective To review the spot protein:creatinine ratio and albumin:creatinine ratio as diagnostic tests for significant proteinuria in hypertensive pregnant women. Design Systematic review. Data sources Medline and Embase, the Cochrane Library, reference lists, and experts. Review methods Literature search (1980-2007) for articles of the spot protein:creatinine ratio or albumin:creatinine ratio in hypertensive pregnancy, with 24 hour proteinuria as the comparator. Results 13 studies concerned the spot protein:creatinine ratio (1214 women with primarily gestational hypertension). Nine studies reported sensitivity and specificity for eight cut-off points, median 24 mg/mmol (range 17-57 mg/mmol; 0.15-0.50 mg/mg). Laboratory assays were not well described. Diagnostic test characteristics were recalculated for a cut-off point of 30 mg/mmol. No significant heterogeneity in cut-off points was found between studies over a range of proteinuria. Pooled values gave a sensitivity of 83.6% (95% confidence interval 77.5% to 89.7%), specificity of 76.3% (72.6% to 80.0%), positive likelihood ratio of 3.53 (2.83 to 4.49), and negative likelihood ratio of 0.21 (0.13 to 0.31) (nine studies, 1003 women). Two studies of the spot albumin:creatinine ratio (225 women) found optimal cut-off points of 2 mg/mmol for proteinuria of 0.3 g/day or more and 27 mg/mmol for albuminuria. Conclusion The spot protein:creatinine ratio is a reasonable “rule-out” test for detecting proteinuria of 0.3 g/day or more in hypertensive pregnancy. Information on use of the albumin:creatinine ratio in these women is insufficient.
212 citations
Cited by
More filters
••
01 Sep 1989
TL;DR: We may not be able to make you love reading, but archaeology of knowledge will lead you to love reading starting from now as mentioned in this paper, and book is the window to open the new world.
Abstract: We may not be able to make you love reading, but archaeology of knowledge will lead you to love reading starting from now. Book is the window to open the new world. The world that you want is in the better stage and level. World will always guide you to even the prestige stage of the life. You know, this is some of how reading will give you the kindness. In this case, more books you read more knowledge you know, but it can mean also the bore is full.
5,075 citations
••
TL;DR: Since 1980, the American College of Cardiology and American Heart Association have translated scientific evidence into clinical practice guidelines (guidelines) with recommendations to improve cardiovascular health.
Abstract: Since 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific evidence into clinical practice guidelines (guidelines) with recommendations to improve cardiovascular health. In 2013, the National Heart, Lung, and Blood Institute (NHLBI) Advisory
4,604 citations
••
TL;DR: The next generation of scientists and decision-makers will have a greater understanding of what constitutes a credible threat to public health and how to protect them from that threat.
3,748 citations
••
Maastricht University1, University of Bologna2, Federation University Australia3, University of Melbourne4, University of Leicester5, University of British Columbia6, Imperial College London7, Public Health Foundation of India8, University of London9, University of Western Australia10, Baker IDI Heart and Diabetes Institute11, National and Kapodistrian University of Athens12, Manchester Academic Health Science Centre13, University of Manchester14, Boston University15, University College London16, North-West University17, University of New South Wales18, The George Institute for Global Health19
TL;DR: Document reviewers: Hind Beheiry (Sudan), Irina Chazova (Russia), Albertino Damasceno (Mozambique), Anna Dominiczak (UK), Stephen Harrap (Australia), Hiroshi Itoh (Japan), Tazeen Jafar (Singapore), Marc Jaffe (USA), Patricio Jaramillo-Lopez (Colombia), Kazuomi Kario (Japan).
Abstract: Document reviewers: Hind Beheiry (Sudan), Irina Chazova (Russia), Albertino Damasceno (Mozambique), Anna Dominiczak (UK), Anastase Dzudie (Cameroon), Stephen Harrap (Australia), Hiroshi Itoh (Japan), Tazeen Jafar (Singapore), Marc Jaffe (USA), Patricio Jaramillo-Lopez (Colombia), Kazuomi Kario (Japan), Giuseppe Mancia (Italy), Ana Mocumbi (Mozambique), Sanjeevi N.Narasingan (India), Elijah Ogola (Kenya), Srinath Reddy (India), Ernesto Schiffrin (Canada), Ann Soenarta (Indonesia), Rhian Touyz (UK), Yudah Turana (Indonesia), Michael Weber (USA), Paul Whelton (USA), Xin Hua Zhang, (Australia), Yuqing Zhang (China).
1,657 citations